Friedhelm Blobel insider trades: Sciclone Pharmaceuticals (SCLN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Friedhelm reports to the SEC
Open-market buys and sales
59 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2017 | SCLN | ↓ Sell | 35,044 | $11.00 | $385K | Direct | Jul 3, 2017 (3d) |
| Jun 20, 2017 | SCLN | ↓ Sell | 70,000 | $10.91 | $764K | Direct | Jun 22, 2017 (2d) |
| Jun 8, 2017 | SCLN | ↓ Sell | 39,656 | $10.52 | $417K | Direct | Jun 9, 2017 (1d) |
| Jun 6, 2017 | SCLN | ↓ Sell | 10,300 | $10.00 | $103K | Direct | Jun 6, 2017 (0d) |
| May 24, 2017 | SCLN | ↓ Sell | 21,464 | $9.32 | $200K | Direct | May 25, 2017 (1d) |
| May 22, 2017 | SCLN | ↓ Sell | 18,536 | $9.44 | $175K | Direct | May 23, 2017 (1d) |
| May 11, 2017 | SCLN | ↓ Sell | 18,226 | $10.00 | $182K | Direct | May 15, 2017 (4d) |
| May 1, 2017 | SCLN | ↓ Sell | 164 | $10.00 | $2K | Direct | May 3, 2017 (2d) |
| Apr 28, 2017 | SCLN | ↓ Sell | 4,400 | $10.01 | $44K | Direct | Apr 28, 2017 (0d) |
| Apr 24, 2017 | SCLN | ↓ Sell | 40,000 | $9.56 | $382K | Direct | Apr 24, 2017 (0d) |
| Mar 22, 2017 | SCLN | ↓ Sell | 40,000 | $9.47 | $379K | Direct | Mar 23, 2017 (1d) |
| Mar 6, 2017 | SCLN | ↓ Sell | 3,087 | $10.30 | $32K | Direct | Mar 8, 2017 (2d) |
| Mar 3, 2017 | SCLN | ↓ Sell | 26,913 | $10.01 | $270K | Direct | Mar 3, 2017 (0d) |
| Feb 24, 2017 | SCLN | ↓ Sell | 823 | $9.71 | $8K | Direct | Feb 27, 2017 (3d) |
| Feb 23, 2017 | SCLN | ↓ Sell | 39,177 | $9.83 | $385K | Direct | Feb 23, 2017 (0d) |
| Jan 25, 2017 | SCLN | ↓ Sell | 8,868 | $10.54 | $93K | Direct | Jan 27, 2017 (2d) |
| Jan 24, 2017 | SCLN | ↓ Sell | 61,132 | $10.44 | $638K | Direct | Jan 24, 2017 (0d) |
| Jan 5, 2017 | SCLN | ↓ Sell | 9,600 | $11.02 | $106K | Direct | Jan 5, 2017 (0d) |
| Dec 22, 2016 | SCLN | ↓ Sell | 70,000 | $10.55 | $738K | Direct | Dec 22, 2016 (0d) |
| Nov 22, 2016 | SCLN | ↓ Sell | 70,000 | $10.22 | $715K | Direct | Nov 23, 2016 (1d) |
| Nov 14, 2016 | SCLN | ↓ Sell | 30,000 | $10.27 | $308K | Direct | Nov 15, 2016 (1d) |
| Oct 27, 2016 | SCLN | ↓ Sell | 40,000 | $9.30 | $372K | Direct | Oct 28, 2016 (1d) |
| Aug 17, 2016 | SCLN | ↓ Sell | 501,875 | $10.00 | $5.0M | Direct | Aug 18, 2016 (1d) |
| Mar 28, 2016 | SCLN | ↓ Sell | 10,000 | $9.29 | $93K | Direct | Mar 30, 2016 (2d) |
| Mar 18, 2016 | SCLN | ↓ Sell | 10,000 | $9.09 | $91K | Direct | Mar 21, 2016 (3d) |
| Mar 7, 2016 | SCLN | ↓ Sell | 20,000 | $10.01 | $200K | Direct | Mar 8, 2016 (1d) |
| Feb 26, 2016 | SCLN | ↓ Sell | 10,000 | $9.98 | $100K | Direct | Mar 1, 2016 (4d) |
| Jan 4, 2016 | SCLN | ↓ Sell | 200 | $9.01 | $2K | Direct | Jan 6, 2016 (2d) |
| Dec 28, 2015 | SCLN | ↓ Sell | 10,000 | $9.17 | $92K | Direct | Dec 29, 2015 (1d) |
| Dec 17, 2015 | SCLN | ↓ Sell | 9,400 | $9.00 | $85K | Direct | Dec 18, 2015 (1d) |
| Dec 11, 2015 | SCLN | ↓ Sell | 600 | $9.00 | $5K | Direct | Dec 14, 2015 (3d) |
| Dec 4, 2015 | SCLN | ↓ Sell | 10,000 | $9.22 | $92K | Direct | Dec 7, 2015 (3d) |
| Nov 27, 2015 | SCLN | ↓ Sell | 10,000 | $9.24 | $92K | Direct | Nov 30, 2015 (3d) |
| Jul 31, 2015 | SCLN | ↓ Sell | 10,000 | $9.15 | $92K | Direct | Aug 3, 2015 (3d) |
| Jul 24, 2015 | SCLN | ↓ Sell | 10,000 | $9.68 | $97K | Direct | Jul 27, 2015 (3d) |
| Jul 17, 2015 | SCLN | ↓ Sell | 10,000 | $9.72 | $97K | Direct | Jul 20, 2015 (3d) |
| Jul 10, 2015 | SCLN | ↓ Sell | 10,000 | $9.21 | $92K | Direct | Jul 14, 2015 (4d) |
| Jul 6, 2015 | SCLN | ↓ Sell | 20,000 | $10.80 | $216K | Direct | Jul 7, 2015 (1d) |
| Jun 26, 2015 | SCLN | ↓ Sell | 10,000 | $9.29 | $93K | Direct | Jun 29, 2015 (3d) |
| Jun 19, 2015 | SCLN | ↓ Sell | 10,000 | $9.42 | $94K | Direct | Jun 22, 2015 (3d) |
| Jun 12, 2015 | SCLN | ↓ Sell | 10,000 | $9.13 | $91K | Direct | Jun 15, 2015 (3d) |
| Jun 5, 2015 | SCLN | ↓ Sell | 10,000 | $9.07 | $91K | Direct | Jun 8, 2015 (3d) |
| May 29, 2015 | SCLN | ↓ Sell | 10,000 | $9.38 | $94K | Direct | Jun 1, 2015 (3d) |
| May 22, 2015 | SCLN | ↓ Sell | 10,000 | $9.40 | $94K | Direct | May 26, 2015 (4d) |
| Apr 24, 2015 | SCLN | ↓ Sell | 10,000 | $9.07 | $91K | Direct | Apr 24, 2015 (0d) |
| Apr 10, 2015 | SCLN | ↓ Sell | 10,000 | $9.10 | $91K | Direct | Apr 13, 2015 (3d) |
| Feb 28, 2014 | SCLN | ↑ Buy | 3,000 | $4.11 | $12K | Direct | Mar 18, 2014 (18d) |
| Feb 28, 2013 | SCLN | ↑ Buy | 3,000 | $3.86 | $12K | Direct | Apr 8, 2013 (39d) |
| Jun 14, 2012 | SCLN | ↓ Sell | 111,000 | $7.04 | $781K | Direct | Jun 18, 2012 (4d) |
| May 31, 2012 | SCLN | ↑ Buy | 1,000 | $3.84 | $4K | Direct | Jun 8, 2012 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Friedhelm Blobel's insider trades
Friedhelm Blobel is President, CEO, Director at Sciclone Pharmaceuticals (SCLN). Since Nov 20, 2007, Friedhelm has reported 12 open-market purchases worth $128K and 47 sales worth $14.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (57 filings), grants and awards (16 filings), shares withheld for taxes (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.